Mitsui Chemicals, Inc.
Stock Price Chart
2026/03/02 UpdatedPrice Trend
2026/03/02 UpdatedPrice & Trading Details
2026/03/02 UpdatedPRICE
TRADING
Analyst Recommendations 12 analysts
Updated 2026/03/01Shareholder Composition
Updated 2026/03/01Dividend History 4Years Growth
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥75 | +3.4% |
| 2024 | ¥73 | +11.5% |
| 2023 | ¥65 | +4.0% |
| 2022 | ¥63 | +19.0% |
| 2021 | ¥53 | - |
Financial Performance
2026/03/01 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,612,688M | ¥1,879,547M | ¥1,749,743M | ¥1,809,164M |
| Gross Profit | ¥378,740M | ¥381,493M | ¥370,797M | ¥388,292M |
| Operating Income | ¥121,491M | ¥107,305M | ¥61,822M | ¥65,907M |
| Pretax Income | ¥153,485M | ¥134,676M | ¥87,994M | ¥86,349M |
| Net Income | ¥109,990M | ¥82,936M | ¥49,999M | ¥32,242M |
| EPS | ¥282.73 | ¥215.59 | ¥131.50 | ¥85.28 |
| Operating Margin | 7.53% | 5.71% | 3.53% | 3.64% |
| Balance Sheet | ||||
| Total Assets | ¥1,934,965M | ¥2,068,203M | ¥2,215,819M | ¥2,153,953M |
| Total Equity | ¥712,654M | ¥786,827M | ¥862,851M | ¥848,284M |
| Total Liabilities | ¥1,222,311M | ¥1,281,376M | ¥1,352,968M | ¥1,305,669M |
| Cash | ¥181,152M | ¥186,310M | ¥210,292M | ¥170,615M |
| Interest-bearing Debt | ¥666,086M | ¥738,249M | ¥756,758M | ¥737,977M |
| Equity Ratio | 36.83% | 38.04% | 38.94% | 39.38% |
| D/E Ratio | 0.93 | 0.94 | 0.88 | 0.87 |
| Cash Flow | ||||
| Operating CF | ¥92,584M | ¥101,241M | ¥161,339M | ¥200,501M |
| Investing CF | -¥205,234M | -¥106,340M | -¥123,939M | -¥165,012M |
| Financing CF | ¥89,222M | ¥2,542M | -¥26,016M | -¥74,437M |
| Free CF | -¥23,632M | -¥36,620M | ¥7,348M | ¥62,095M |
| Efficiency | ||||
| ROE | 15.43% | 10.54% | 5.79% | 3.80% |
| ROA | 5.68% | 4.01% | 2.26% | 1.50% |
Latest IR Information
-
Announcement on the Status of Treasury Stock Acquisition (Treasury Stock Acquisition Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)
Announced acquisition of 1,898,000 shares of treasury stock totaling ¥4,450,403,486 from February 6 to February 28, 2026. The acquisition limit is set at 18,400,000 shares and ¥30 billion, with the period until July 31.
Read more -
Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [IFRS] (Consolidated)
For the third quarter of the fiscal year ending March 2026, revenue was 1,218.7 billion yen (down 9.0% YoY), operating income was 54.6 billion yen (down 18.3% YoY), and net income attributable to owners of parent for the quarter was...
Read more -
Summary of Q3 FY2025 Financial Results and FY2025 Earnings Guidance
Core operating income for Q3 FY2025 was 68 billion yen (down 10% YoY), and full-year guidance has been revised downward to 103 billion yen. A share buyback of 30 billion yen is planned to strengthen shareholder returns.
Read more -
Notice Regarding the Resolution on Matters Concerning the Share Buyback and Share Cancellation (Share Buyback Based on the Provisions of Article 165, Paragraph 2 of the Companies Act, and Share Cancellation Based on the Provisions of Article 178 of the Companies Act)
Mitsui Chemicals will conduct a share buyback with an upper limit of 18,400,000 shares and up to 30 billion yen from February 6, 2026, to July 31, 2026, aiming to improve capital efficiency and enhance shareholder returns. Following the buyback,...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥2,363
Rating Score: 2.00 (Based on 12 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Mitsui Chemicals, Inc. engages in the mobility, life and health care, basic and green materials, ICT, and other businesses worldwide. The company offers vision care materials, nonwoven fabrics and personal care materials, agricultural chemicals, and oral care materials; and elastomers, performance and polypropylene compounds, and other materials. It also provides semiconductor solutions, such as electronic component processing materials, optical materials, and lithium-ion battery materials; functional food packaging materials; imaging solutions, such as lens materials, materials for reflective films, and LCD and OLED sealing materials; battery material solutions; and converting solutions, including heat sealants, barrier coating materials, and packaging adhesives. In addition, the company offers petrochemicals, which comprise ethylene, propylene, high- and low-density polyethylene; basic chemicals, such as phenol, bisphenol, acetone, isopropyl alcohol, methyl isobutyl ketone, purified terephthalic acid, PET resin, ethylene oxide and glycol, hydroquinone, meta/para-cresol, ammonia, urea, and melamine; and polyurethane raw materials, as well as develops DNA microarrays. Further, it provides life care solutions, such as ophthalmic lens materials, photochromic lens materials, coating materials, nonwovens, breathable films, filtration devise, acrylamide, methacrylamide, and synthetic pulp; agrochemical products, including insecticides, fungicides, herbicides, non-crop specialty chemicals, pet medication ingredients; and medical solutions, restoratives, adhesives, artificial teeth, denture materials, impression, digital equipment/materials, medical materials, genetic testing, and contract genetic analysis services. It sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.